PXD022915 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Proteomics analysis of gastric cancer patients with diabetes mellitus |
Description | Proteomics is a powerful approach to study the molecular mechanisms of cancer. In this study, we aim to characterize the proteomic profile of gastric cancer (GC) from patients with diabetes mellitus (DM). Forty gastric cancer tissue samples including 19 cases from diabetic patients, and 21 cases from individuals without diabetes (control group), were selected for proteomics analysis. Gastric tissues were lysed, sonicated and the resulting protein content was determined. One hundred g of proteins from each sample were processed following the single-pot, solid-phase-enhanced sample preparation approach – SP3 and enzymatically digested with trypsin. The resulting peptides were analyzed by LC-MS mass spectrometry. Comparison of protein expression levels between GC samples from diabetic and non-diabetic patients was performed by label-free quantification - LFQ. A total of 6599 protein groups were identified among the 40 samples. Two hundred-twenty proteins with at least two unique peptides were differentially expressed among the two groups (adjusted p-value < 0.05), 102 being upregulated and 118 downregulated in the diabetic cohort. Statistical overrepresentation tests were considered for different annotation sets including GO, KEGG, Reactome including Disease functional databases. Upregulated proteins in GC samples from diabetic patients showed a strong fold enrichment associated with respiratory electron transport and alcohol metabolic biological processes, while downregulated proteins were associated with cell-cell junction cellular components. Six proteins were exclusively detected in GC samples from diabetic patients, while 11 proteins were found to be absent in this group. |
HostingRepository | PRIDE |
AnnounceDate | 2021-01-22 |
AnnouncementXML | Submission_2021-02-08_22:19:50.xml |
DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD022915 |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Hugo Osorio |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | iodoacetamide derivatized residue |
Instrument | Q Exactive |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2020-12-04 03:03:56 | ID requested | |
1 | 2021-01-21 23:46:03 | announced | |
⏵ 2 | 2021-02-08 22:19:51 | announced | 2021-02-09: Updated publication reference for PubMed record(s): 33494396. |
3 | 2021-03-17 05:11:53 | announced | 2021-03-17: Updated project metadata. |
4 | 2021-03-18 03:21:19 | announced | 2021-03-18: Updated project metadata. |
Publication List
Os, ó, rio H, Silva C, Ferreira M, Gullo I, M, á, ximo V, Barros R, Mendon, ç, a F, Oliveira C, Carneiro F, Proteomics Analysis of Gastric Cancer Patients with Diabetes Mellitus. J Clin Med, 10(3):(2021) [pubmed] |
Keyword List
submitter keyword: gastric cancer (GC) |
diabetes mellitus (DM) |
proteomics |
label free quantification (LFQ) |
Contact List
Hugo Osorio |
contact affiliation | i3S - Institute for Research and Innovation in Health, University of Porto, Portugal |
contact email | hosorio@i3s.up.pt |
lab head | |
Hugo Osorio |
contact affiliation | i3S - Institute for Research and Innovation in Health, University of Porto |
contact email | hosorio@i3s.up.pt |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD022915 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD022915
- Label: PRIDE project
- Name: Proteomics analysis of gastric cancer patients with diabetes mellitus